浙江省人民医院妇科 2022 年 6 月—2024 年 1 月收治 3 例腹膜后局限性复发妇科恶性肿瘤的患者，经过充分的术前评估， 行机器人辅助腹腔镜下腹膜后肿瘤切除术。 3 例手术均顺利完成，平均手术时长 158.3 min，平均术后首次排气 31.3 h，平均 住院时间 7.7 d，随访时间 4~22 个月，随访期间未见明显复发征象。手术过程中无脏器损伤或明显血管损伤，术后 1 例患者 出现淋巴漏。结果表明，结合适当体位，机器人辅助腹腔镜手术可以精确完成腹膜后局限性复发肿瘤切除，且能够降低并发 症的发生，促进患者术后恢复。

From June 2022 to January 2024, 3 patients with localized retroperitoneal recurrence of gynecological malignancies were treated at the Department of Gynecology, Zhejiang Provincial People’s Hospital. After comprehensive preoperative evaluation, robotassisted laparoscopic retroperitoneal tumor resection was performed. All surgeries were successfully completed with a mean operative time of 158.3 min. The average time to first postoperative flatus was 31.3 h, and the average length of hospital stay was 7.7 d. During follow-up of 4 to 22 months, no signs of obvious recurrence were observed. No intraoperative visceral or significant vascular injuries occurred. 1 patient developed postoperative lymphatic leakage. The results indicated that robot-assisted laparoscopic surgery combined with appropriate positioning can precisely complete locally recurrent retroperitoneal tumor excisions with reduced complications and accelerated postoperative recovery.

基金项目：国家中医药管理局科技司 - 浙江省中医药管理局共建科技计划项目重点项目（TGY24H160110）；浙江省医药卫生科学研究基 金一般项目（2020KY020）；浙江省公益探索项目（TGY24H160110） 

Foundation Item: Key Project of the Co-constructed Science and Technology plan of the Science and Technology Department of National  Administration of Traditional Chinese Medicine and Zhejiang Administration of Traditional Chinese Medicine(TGY24H160110); General  Project of Zhejiang Province Medical and Health Science Research Fund(2020KY020); Exploration Project of Zhejiang Province for Public  Welfare(TGY24H160110) 

引用格式：徐胡斌，江海敏，曾文杰，等 . 机器人辅助腹腔镜治疗腹膜后局限性复发妇科恶性肿瘤病灶 3 例报道（附手术视频）[J]. 机器人 外科学杂志（中英文），2025，6（5）：769-774. 

Citation: XU H B, JIANG H M, ZENG W J, et al. Robot-assisted laparoscopic surgery for locally recurrent retroperitoneal gynecologic  malignancies: a report of 3 cases(with surgical video)[J]. Chinese Journal of Robotic Surgery, 2025, 6(5): 769-774. 

通讯作者（Corresponding Author）：寿华锋（SHOU Huafeng），Email：hfshou@126.com

[1] 中华医学会 , 中华医学会肿瘤学分会 , 中华医学会杂志社 , 等 . 中国 腹膜后肿瘤诊治专家共识 (2019 版 )[J]. 中华肿瘤杂志 , 2019, 41(10): 728-733. 

[2] 郝纯毅 , 吴剑挥 . 原发性腹膜后软组织肉瘤诊治中国专家共识 (2019 版 )[J/OL]. 中国实用外科杂志 , 2019, 39(6): 526-532. 

[3] 贺良 , 顾炯 , 汪雷 , 等 . 三维可视化技术在腹膜后肿瘤切除术中应用 研究 [J]. 肝胆外科杂志 , 2023, 31(4): 263-266. 

[4] 无通道系统单孔腹腔镜治疗肥胖患者输卵管妊娠效果观察 [J]. 人民 军医 , 2021, 5 (64): 437-441. 

[5] Dood R L, Zhao Y, Armbruster S D, et al. Defining survivorship trajectories across patients with solid tumors: an evidence-based approach[J/OL]. JAMA Oncology, 2018, 4(11): 1519. 

[6] Marchetti C, Fagotti A, Tombolini V, et al. The role of secondary cytoreductive surgery in recurrent ovarian cancer: a systematic review and Meta-analysis[J/OL]. Annals of Surgical Oncology, 2021, 28(6): 3258-3263. 

[7] Liberis A, Kyziridis D, Kalakonas A, et al. Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience[J/OL]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2024. DOI: 10.1016/j.ejogrb.2023.11.021. 

[8] Musella A, Marchetti C, Palaia I, et al. Secondary cytoreduction in platinum-resistant recurrent ovarian cancer: a single-institution experience[J/OL]. Annals of Surgical Oncology, 2015, 22(13): 4211-4216. 

[9] Petrillo M, Pedone Anchora L, Tortorella L, et al. Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysis[J/OL]. Gynecologic Oncology, 2014, 134(2): 257-261. 

[10] Petrillo M, Fagotti A, Ferrandina G, et al. Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors[J/OL]. Gynecologic Oncology, 2013, 131(1): 36-41. 

[11] 卢淮武 , 徐冬冬 , 赵喜博 , 等 .《2024 NCCN 卵巢癌包括输卵管癌及 原发性腹膜癌临床实践指南 ( 第 1 版 )》解读 [J]. 中国实用妇科与产 科杂志 , 2024, 40(2): 187-197.

[12] 鲍洢婷 , 尧良清 , 袁蕾 . 肿瘤细胞减灭术在复发性卵巢癌中的应用进 展 [J]. 中国妇幼保健 , 2023, 38(24): 4973-4976. 

[13] 蓝春燕 , 王雅卓 , 张师前 . 铂敏感复发性卵巢癌诊治中国专家共识 (2023 年版 )[J/OL]. 中国实用妇科与产科杂志 , 2023, 39(9): 935-942. 

[14] Suh D H, Kim H S, Chang S J, et al. Surgical management of recurrent ovarian cancer[J/OL]. Gynecologic Oncology, 2016, 142(2): 357-367. 

[15] Armstrong D K, Alvarez R D, Backes F J, et al. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022: Featured Updates to the NCCN Guidelines[J/OL]. Journal of the National Comprehensive Cancer Network, 2022, 20(9): 972-980. 

[16] Taarnhøj G A, Christensen I J, LAJER H, et al. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005- 2013: A national cohort study[J/OL]. Cancer, 2018, 124(5): 943-951. 

[17] CHEN Y Y, ZHU Y M, WU J C. Prognosis of early stage cervical cancer according to patterns of recurrence[J/OL]. Cancer Management and Research, 2021. DOI: 10.2147/CMAR.S314384. 

[18] LI J, LIU G, LUO J, et al. Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study[J/ OL]. Scientific Reports, 2022, 12(1): 13994. 

[19] Abu-Rustum N R, Yashar C M, Arend R, et al. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024: featured updates to the NCCN guidelines[J/OL]. Journal of the National Comprehensive Cancer Network, 2023, 21(12): 1224-1233. 

[20] 周晖 , 刘昀昀 , 罗铭 , 等 .《2024 NCCN 子宫颈癌临床实践指南 ( 第 1 版 )》更新解读 [J]. 中国实用妇科与产科杂志 , 2023, 39(11): 1119- 1121.

[21] 刘颖蔚 , 杜凯玟 , 唐均英 . 机器人手术系统在妇科恶性肿瘤中的应用 及优势 [J]. 实用妇产科杂志 , 2023, 39(10): 730-732. 

[22] 李道云 , 徐云 , 芮小慧 . 机器人辅助腹腔镜手术在妇科疾病中的应 用 [J]. 机器人外科学杂志 ( 中英文 ), 2023, 4(6): 540-548. 

[23] 魏勇 , 王省博 , 左文仁 , 等 . 经腹膜后入路机器人辅助单孔腹腔镜肾 部分切除治疗孤立肾肾癌合并双肾盂双输尿管畸形一例报道 [J]. 机 器人外科学杂志 ( 中英文 ), 2023, 1 (4): 79-84. 

[24] 陈雨柔 , 张蔚 . 妇科恶性肿瘤腹腔镜下腹膜外腹主动脉旁淋巴结切 除术的意义探讨 [J/OL]. 现代妇产科进展 , 2017, 26(8): 624-626. 

[25] Ngô C, Cornou C, Rossi L, et al. Evidence for the use of robotically assisted surgery in gynecologic cancers[J/OL]. Current Opinion in Oncology, 2016, 28(5): 398-403. 

[26] 达芬奇机器人手术系统行妇科手术 606 例临床分析 [J]. 机器人外科 学杂志 ( 中英文 ), 2020(02 vo 1): 102-107. 

[27] ZHANG W, LI H Y, CUI L L, et al. Research progress and development trend of surgical robot and surgical instrument arm[J/OL]. Int J Med Robot, 2021, 17(5): e2309. 

[28] SHI C, GAO Y C, YANG Y J, et al. Comparison of efficacy of robotic surgery, laparoscopy, and laparotomy in the treatment of ovarian cancer: a meta-analysis[J/OL]. World Journal of Surgical Oncology, 2019, 17(1): 162. 

[29] Escobar P F, Levinson K L, Magrina J, et al. Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: A multi-institutional study[J/OL]. Gynecologic Oncology, 2014, 134(2): 253-256. 

[30] Magrina J F, Cetta R L, Chang Y H, et al. Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy[J/OL]. Gynecologic Oncology, 2013, 129(2): 336-340. 

[31] 宋可 , 张雪 , 安晓华 . 腹腔镜腹膜后肾脏肿瘤切除术中患者 30° 折腰 水平侧卧体位摆放的应用效果 [J]. 山东医药 , 2022, 22(62): 78-80. 

[32] Rivas-López R, Sandoval-García-Travesí F A. Cirugía robótica en ginecología: revisión de la literatura[J/OL]. Cirugíay Cirujanos, 2020, 88(1): 1332. 

[33] Loverix L, Salihi R R, van Nieuwenhuysen E, et al. Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy[J/OL]. International Journal of Gynecologic Cancer, 2020, 30(4): 466-472. 

[34] Bruno V, Chiofalo B, Logoteta A, et al. Urological complications in radical surgery for cervical cancer: a comparative meta-analysis before and after LACC trial[J/OL]. Journal of Clinical Medicine, 2023, 12(17): 5677. 

[35] Lawrie T A, Liu H, Lu D, et al. Robot-assisted surgery in gynaecology[J/ OL]. Cochrane Database of Systematic Reviews, 2019, 4(4): CD011422. 

[36] Capozzi V, Scarpelli E, Armano G, et al. Update of robotic surgery in benign gynecological pathology: systematic review[J/OL]. Medicina, 2022, 58(4): 552